期刊文献+

基质金属蛋白酶-9及其组织抑制物-1诊断胎膜早破并绒毛膜羊膜炎的临床价值 被引量:8

Clinical significance of MMP-9/TIMP-1 in patients with premature rupture of the membranes complicated with chorioamniotitis.
暂未订购
导出
摘要 目的:探讨母血、羊水、脐血中基质金属蛋白酶-9(MMP-9)及其组织抑制物-1(TIMP-1)的水平变化与胎膜早破发生的相关性,分析它作为一种新型的生物学标志物对绒毛膜羊膜炎和新生儿预后判断的临床价值。方法:采用双抗体夹心酶联免疫吸附法检测58例胎膜早破及38例正常孕妇(对照组)母血、羊水、脐血中MMP-9/TIMP-1水平的动态变化,同时进行胎膜的病理检查。结果:胎膜早破组母血、羊水、脐血中MMP-9的含量均高于对照组,尤以羊水中MMP-9水平升高明显,与对照组差异有显著性(P<0.05,P<0.01);而TIMP-1水平变化则明显低于对照组,差异有显著性(P<0.05,P<0.01)。母血、羊水、脐血中MMP-9的含量随破膜时间的延长增高,破膜时间超过24h增高尤为明显。而TIMP-1则随破膜时间的延长而下降,破膜时间超过24h降低尤为明显。绒毛膜羊膜炎患者母血、羊水、脐血中MMP-9水平明显高于非绒毛膜羊膜炎患者,差异有显著性(P<0.05,P<0.01),而TIMP-1水平则明显低于非绒毛膜羊膜炎患者,差异具有显著性(P<0.05,P<0.01)。胎膜早破组产妇所生新生儿Apgar评分≤7分者的母血、羊水、脐血中MMP-9的含量显著高于Apgar≥8分的新生儿(P<0.05,P<0.01),胎膜早破组新生儿Apgar评分≤7分者的母血、羊水、脐血中TIMP-1含量则显著低于Apgar≥8分的新生儿(P<0.05,P<0.01)。结论:MMP-9的异常升高及其抑制物TIMP-1显著下降是胎膜早破发生的重要发病机制。MMP-9/TIMP-1含量变化可以成为一种新的生物学标志用于早期诊断胎膜早破并绒毛膜羊膜炎特别是尚处于亚临床感染状态的孕妇,并有助于评估新生儿预后。 Objective: To investigate the clinical roles of matrix metalloproteinase (MMP-9) and tissue inhibitors of matrix metalloproteinase ( TIMP-1 ) in predicting premature rupture of the membranes (PROM) and chorioamnionitis. Methods: The levels of MMP-9 and TIMP-I were detected by enzyme linked immunosorbent assay in maternal serum,amniotic fluid, umbilical cord serum of 58 pregnant women with PROM and 38 women with normal pregnancies. Chorioamnionitis was histopathologically confirmed after delivery. Results: The levels of MMP-9 were significantly higher and TIMP-1 were significantly lower in maternal serum, amni- otic fluid, umbilical cord serum in patients with PROM than those of the control group (P 〈O. 05 ,P 〈 0.01 ). The longer the duration from rupture of membrances to delivery it was, the more serious chorioamnionitis it had, and the higher the levels of MMP-9 and the lower of TIMP- 1 in maternal serum, amniotic fluid, umbilical cord serum were. The levels of MMP-9 were significantly higher and TIMP-1 were significantly lower in maternal serum, amniotic fluid, umbilical cord serum in patients with chorioamnionitis than those of non-chorioamnionitis(P 〈 0.05 ,P 〈 0.01 ). The levels of MMP-9 were significantly higher and TIMP-1 were significantly lower in maternal serum, amniotic fluid, umbilical cord serum in neonates whose Apgar score ≤7 than those of neonates whose Apgar score ≥8. Conclusion:PROM is associated with increased MMP- 9 and decreased TIMP-1 levels. MMP-9 and TIMP-1 were the valuable clinical biological markers for identifying the chorioamnionitis and predicting neonatal prognosis.
出处 《现代妇产科进展》 CSCD 北大核心 2005年第5期381-384,共4页 Progress in Obstetrics and Gynecology
基金 江苏省社会发展科技计划资助项目(BS2001018)
关键词 基质金属蛋白酶-9 金属蛋白酶类组织抑制剂 胎膜早破 绒毛膜羊膜炎 Matrix metalloproteinase-9 Tissue inhibitor of metalloproteinases Fetal membranes, premature rupture Chorioamnionitis
  • 相关文献

参考文献12

  • 1张志诚.临床产科学[M].天津:天津科学技术出版社,1994.211.
  • 2Shapiro SD. Matrix metalloproteinase degradation of extracellular matrix: biological consequences [J]. Curr Opin Cell Biol, 1998,10:602-608.
  • 3Fortunato SJ, Menon R. Screening of novel matrix metalloproteinases ( MMPs ) in human fetal membranes [J]. J Assist Reprod Genet,2002,19:483-486.
  • 4Lei H, Kalluri R, Furth EE, Baker AH, et al. Rat amnion type Ⅳ collagen composition and metabolism:implications for membrane breakdown [J]. Biol Reprod, 1999,60: 176-182.
  • 5Maymon E, Romero R, Pacora P, et al. Evidence for the participation of interstitial collagenase (matrix metalloproteinase 1 ) in preterm premature rupture of membranes [J]. Am J Obstet Gynecol,2000,183:914-920.
  • 6Maj JG, Kankofer M. Activity of 72-kDa and 92-kDa matrix metalloproteinases in placental tissues of cows with and without retained fetal membranes [J]. Placenta, 1997,18:683-687.
  • 7郭建新,李力,陈竹钦,郑英如,姚宏.羊水中明胶酶、白细胞介素8与胎膜早破关系的研究[J].中华围产医学杂志,2004,7(1):25-28. 被引量:7
  • 8Locksmith GJ, Clark P, Duff P, et al. Amniotic fluid concentrations of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 duringpregnancy and labor[J].Am J Obstet Gynecol,2001,184:159-164.
  • 9Maymon E, Romero R, Pacora P, et al. Evidence of in vivo differential bioavailability of the active forms of matrix metalloproteinases 9 and 2 in parturition, spontaneous rupture of membranes, and intra-amniotic infection[J]. Am J Obstet Gynecol,2000,183:887-894.
  • 10Maymon E, Romero R, Chaiworapongsa T, et al. Amniotic fluid matrix metalloproteinase-8 in preterm labor with intact membranes [J]. Am J Obstet Gynecol, 2001,185:1149-1155.

共引文献55

同被引文献72

引证文献8

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部